Table: Fuji Pharmaceutical -Q1 group results

Fuji Pharma

08/02/2024 08:00

Feb 8 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Dec 31, 2023        Sep 30, 2023     Sep 30, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             10.75               10.00            48.93    
                 (+7.5 pct)          (+5.8 pct)       (+19.7 pct) 
  Operating     loss 140 mln             1.19             4.91    
                                     (-23.8 pct)      (+27.2 pct) 
  Recurring      loss 96 mln             1.58             5.56    
                                     (-0.1 pct)       (+23.1 pct) 
  Net                2.74                1.11             6.19    
                (+145.8 pct)         (-0.3 pct)       (+80.0 pct) 
  EPS            112.73 yen           45.88 yen       254.51 yen  
  Ann Div                             37.00 yen        42.50 yen  
  -Q2 div                             17.00 yen        20.00 yen  
  -Q4 div                             20.00 yen        22.50 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T